Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 70 (2), 140-4

Screening for MECP2 Mutations in Spanish Patients With an Unexplained Mental Retardation

Affiliations

Screening for MECP2 Mutations in Spanish Patients With an Unexplained Mental Retardation

M-I Tejada et al. Clin Genet.

Abstract

Rett syndrome (RTT) is an X-linked progressive encephalopathy. Mutations in the MECP2 (methyl-CpG-binding protein) gene have been found to cause RTT. In the past few years, the role of MECP2 mutations in patients with mental disorders other than RTT has been studied, finding that mutations in MECP2 also contribute to non-syndromic entities. More recently, it has been demonstrated that RTT shares clinical features with those of Angelman syndrome, another neurodevelopmental disorder. These observations must be confirmed in a large series, to better understand the criteria needed for justifying a molecular test. Consequently, we have searched for MECP2 mutations in 294 patients (43 Angelman and Prader-Willi like included) with mental retardation (MR) of unknown aetiology. We found six polymorphisms (three novel, three previously reported) in 10 patients, one novel unclassified silent change (p.V222V) in a man, and one causative mutation in a girl with MR. Once this case was clinically reviewed, the girl presented symptoms of atypical RTT. The mutation (p.Y141C) lies within the methyl-binding domain, and has only been reported once in another atypical RTT. Our results show that the MECP2 mutations account for a low frequency (1/416 chromosomes = 0.24%) among mentally retarded individuals, which imply that it is necessary to perform an exhaustive clinical examination of patients before determining whether analysis of MECP2 is required or not.

Similar articles

See all similar articles

Cited by 4 PubMed Central articles

  • The Array of Clinical Phenotypes of Males With Mutations in Methyl-CpG Binding Protein 2
    JL Neul et al. Am J Med Genet B Neuropsychiatr Genet 180 (1), 55-67. PMID 30536762.
    Mutations in the X-linked gene MECP2 are associated with a severe neurodevelopmental disorder, Rett syndrome (RTT), primarily in girls. It had been suspected that mutatio …
  • Regulatory Functions and Pathological Relevance of the MECP2 3'UTR in the Central Nervous System
    H McGowan et al. Cell Regen (Lond) 4, 9. PMID 26516454.
    Methyl-CpG-binding protein 2 (MeCP2), encoded by the gene MECP2, is a transcriptional regulator and chromatin-remodeling protein, which is ubiquitously expressed and play …
  • Rett Syndrome and MeCP2
    VR Liyanage et al. Neuromolecular Med 16 (2), 231-64. PMID 24615633. - Review
    Rett syndrome (RTT) is a severe and progressive neurological disorder, which mainly affects young females. Mutations of the methyl-CpG binding protein 2 (MECP2) gene are …
  • MECP2 Mutations in Males
    L Villard. J Med Genet 44 (7), 417-23. PMID 17351020. - Review
    Rett syndrome (RS; MIM 312750) is a severe neurological disorder affecting exclusively females. Its prevalence is about 1 in 10,000 female births, and it is a prominent c …

Publication types

Substances

LinkOut - more resources

Feedback